FHA
MDGL icon

First Horizon Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

First Horizon Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$46.6K Sell
154
-3
-2% -$894 ﹤0.01% 1040
2025
Q1 		$52K Buy
157
+44
+39% +$14.5K ﹤0.01% 911
2024
Q4 		$34.9K Sell
113
-2
-2% -$563 ﹤0.01% 1108
2024
Q3 		$24.4K Buy
115
+11
+11% +$2.81K ﹤0.01% 1283
2024
Q2 		$29.1K Buy
104
+98
+1,633% +$23.3K ﹤0.01% 1141
2024
Q1 		$1.6K Buy
6
+2
+50% +$471 ﹤0.01% 2076
2023
Q4 		$925 Hold
4
– – ﹤0.01% 2232
2023
Q3 		$584 Buy
+4
New +$753 ﹤0.01% 2300

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Horizon Advisors's MDGL Position: Q2 2025 in Review

First Horizon Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 1.9% in Q2 2025, selling an estimated $894 and leaving 154 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1040.

First Horizon Advisors first reported a position in MDGL in Q3 2023 and has held it in 8 quarters since. The position peaked at $52K in Q1 2025. 305 funds tracked by Wall St. Rank hold MDGL as of Q2 2025.

  • First Horizon Advisors held 154 shares of Madrigal Pharmaceuticals worth $46.6K as of Q2 2025.
  • First Horizon Advisors sold 3 Madrigal Pharmaceuticals shares in Q2 2025, an estimated $894.
  • Madrigal Pharmaceuticals made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1040 holding.
  • First Horizon Advisors first reported a position in Madrigal Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
  • First Horizon Advisors's Madrigal Pharmaceuticals position peaked at $52K in Q1 2025.
  • 305 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.